First human tests begin for new immune drug
NCT ID NCT04052360
Summary
This early research study tested a single dose of an experimental drug called cenerimod in 20 healthy volunteers. The goal was to check its safety and see how the body absorbs and processes it. Researchers compared results between 10 Japanese and 10 Caucasian participants to look for any differences.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anaheim Clinical Trials
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.